Assignee
HK INNO N CORP
KR·13 granted patents·21 pending applications·1 citations·filing 2017–2025
Top patents by PatentIndex Score
34 records- 0184US12358900B2Acid addition salts of benzimidazole derivativeHK INNO N CORP·Filed 2024·Granted Jul 15, 2025·0 cites·20 claims
- 0280US2025304562A1Acid addition salts of benzimidazole derivativeHK INNO N CORP·Filed 2025·Application pending·0 cites
- 0379US11912690B2Acid addition salts of benzimidazole derivativeHK INNO N CORP·Filed 2022·Granted Feb 27, 2024·0 cites·20 claims
- 0479US11535610B2Acid addition salts of benzimidazole derivativeHK INNO N CORP·Filed 2017·Granted Dec 27, 2022·1 cites·13 claims
- 0573US2025241897A1Composition for eradicating helicobacter pyloriHK INNO N CORP·Filed 2024·Application pending·0 cites
- 0669US2025248974A1Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitorHK INNO N CORP·Filed 2024·Application pending·0 cites
- 0768US11780810B2Intermediates for optically active piperidine derivatives and preparation methods thereofHK INNO N CORP·Filed 2022·Granted Oct 10, 2023·0 cites·13 claims
- 0867US11254641B2Intermediates for optically active piperidine derivatives and preparation methods thereofHK INNO N CORP·Filed 2018·Granted Feb 22, 2022·0 cites·3 claims
- 0966US12128030B2Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitorHK INNO N CORP·Filed 2019·Granted Oct 29, 2024·0 cites·19 claims
- 1061US2021196685A1Composition for eradicating helicobacter pyloriHK INNO N CORP·Filed 2019·Application pending·0 cites
- 1160US2023277506A1Novel preparation containing benzimidazole derivativeHK INNO N CORP·Filed 2023·Application pending·0 cites
- 1259US2023087865A1Pharmaceutical composition for oral administrationHK INNO N CORP·Filed 2021·Application pending·0 cites
- 1358US2025213692A1Anti-hla-g chimeric antigen receptor, and use thereofHK INNO N CORP·Filed 2023·Application pending·0 cites
- 1457US10828253B2Composition for injectionHK INNO N CORP·Filed 2018·Granted Nov 10, 2020·0 cites·15 claims
- 1557US2025051287A1Method for preparation of benzimidazole derivativesHK INNO N CORP·Filed 2022·Application pending·0 cites
- 1657US2025297013A1Hla-g-specific antibody and use thereofHK INNO N CORP·Filed 2023·Application pending·0 cites
- 1757US2020368185A1Combination formulation containing sustained release metformin and immediate release hmg-coa reductase inhibitorHK INNO N CORP·Filed 2020·Application pending·0 cites
- 1856US11033532B2Uses of benzimidazole derivative for nocturnal acid breakthroughHK INNO N CORP·Filed 2019·Granted Jun 15, 2021·0 cites·23 claims
- 1955US2024246948A1Benzamide derivative, method for preparing same, and pharmaceutical composition for prevention or treatment of cancer containing same as active ingredientHK INNO N CORP·Filed 2022·Application pending·0 cites
- 2054US11576898B2Preparation containing benzimidazole derivativeHK INNO N CORP·Filed 2017·Granted Feb 14, 2023·0 cites·7 claims
- 2154US2023201164A1Pharmaceutical composition comprising benzimidazole derivative compoundHK INNO N CORP·Filed 2021·Application pending·0 cites
- 2253US2023381109A1Orally disintegrating tablet comprising benzimidazole derivative compound and preparation method thereofHK INNO N CORP·Filed 2021·Application pending·0 cites
- 2353US2023248703A1Pharmaceutical composition comprising benzimidazole derivative compoundHK INNO N CORP·Filed 2020·Application pending·0 cites
- 2453US2023158001A1Pharmaceutical composition comprising benzimidazole derivative compoundHK INNO N CORP·Filed 2021·Application pending·0 cites
- 2552US2025319071A1Pharmaceutical composition comprising tegoprazan and non-steroidal anti-inflammatory drugsHK INNO N CORP·Filed 2021·Application pending·0 cites
- 2651US2024051957A1Crystalline form of heterocyclic compound as protein kinase inhibitorHK INNO N CORP·Filed 2022·Application pending·0 cites
- 2749US2024300943A1Novel salts of heterocyclic compound as protein kinase inhibitor and uses thereofHK INNO N CORP·Filed 2022·Application pending·0 cites
- 2846US12077523B2N-(isopropyl-triazolyl)pyridinyl)-heteroaryl-carboxamide derivatives and use thereofHK INNO N CORP·Filed 2019·Granted Sep 3, 2024·0 cites·24 claims
- 2945US2024270859A1ANTI-OX40L ANTIBODY, ANTI-OX40L/ANTI-TNFa BISPECIFIC ANTIBODY, AND USES THEREOFHK INNO N CORP·Filed 2020·Application pending·0 cites
- 3043US12565491B2(Isopropyl-triazolyl)pyridinyl-substituted benzooxazinone or benzothiazinone derivatives and use thereofHK INNO N CORP·Filed 2019·Granted Mar 3, 2026·0 cites·20 claims
- 3143US12180185B2Compound as protein kinase inhibitor, and pharmaceutical composition comprising thereofHK INNO N CORP·Filed 2019·Granted Dec 31, 2024·0 cites·10 claims
- 3243US2021355452A1Purification method for vaccine virus using affinity chromatographyHK INNO N CORP·Filed 2019·Application pending·0 cites
- 3342US2022125764A1Pharmaceutical composition comprising benzimidazole derivative compoundHK INNO N CORP·Filed 2020·Application pending·0 cites
- 3438US11524968B2Heterocyclic compound as a protein kinase inhibitorHK INNO N CORP·Filed 2018·Granted Dec 13, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when HK INNO N CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →